Publikationen von G Hagberg

Kumlien, E.; Nilsson, A.; Hagberg, G.; Långström, B.; Bergström, M.: PET with 11C-deuterium-deprenyl and 18F-FDG in focal epilepsy. Acta Neurologica Scandinavica 103 (6), S. 360 - 366 (2001)

Mader, I.; Roser, W.; Kappos, L.; Hagberg, G.; Seelig, J.; Radue, E.; Steinbrich, W.: Serial proton MR spectroscopy of contrast-enhancing multiple sclerosis plaques: absolute metabolic values over 2 years during a clinical pharmacological study. American Journal of Neuroradiology 21 (7), S. 1220 - 1227 (2000)

Lindström, L.; Gefvert, O.; Hagberg, G.; Lundberg, T.; Bergström , M.; Hartvig, P.; Långström, B.: Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(β-11C) DOPA and PET. Biological Psychiatry 46 (5), S. 681 - 688 (1999)

Sihver, W.; Fasth, K.-J.; Horti, A.; Koren, A.; Bergström, M.; Lu, L.; Hagberg, G.; Lundqvist, H.; Dannals, R.; London, E. et al.; Nordberg, A.; Långström, B.: Synthesis and Characterization of Binding of 5-[76Br] Bromo-3-[[2(S)-Azetidinyl]methoxy]pyridine, a Novel Nicotinic Acetylcholine Receptor Ligand, in Rat Brain. Journal of Neurochemistry: official journal of the International Society for Neurochemistry 73 (3), S. 1264 - 1272 (1999)

Tedroff, J.; Ekesbo, A.; Rydin, E.; Långström, B.; Hagberg, G.: Regulation of dopaminergic activity in early Parkinson's disease. Annals of Neurology 46 (3), S. 359 - 365 (1999)

Hagberg, G.: From magnetic resonance spectroscopy to classification of tumors. A review of pattern recognition methods. NMR in Biomedicine 11 (4-5), S. 148 - 156 (1998)

Hagberg, G.; Gefvert, O.; Bergström, M.; Wieselgren, I.-M.; Lindström, L.; Wiesel, F.-A.; Långström, B.: N-[11C]Methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic. Psychiatry Research: Neuroimaging 82 (3), S. 147 - 160 (1998)

Roser, W.; Hagberg, G.; Mader, I.; Dellas, S.; Seelig, J.; Radue, E.; Steinbrich, W.: Assignment of glial brain tumors in humans byin vivo 1H-magnetic resonance spectroscopy and multidimensional metabolic classification. Magnetic Resonance Materials in Physics, Biology and Medicine 5 (3), S. 179 - 183 (1997)

Mader, I.; Roser, W.; Hagberg, G.; Schneider, M.; Sauter, R.; Seelig, J.; Radue, E.; Steinbrich, W.: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. Magnetic Resonance Materials in Physics, Biology and Medicine 4 (2), S. 139 - 150 (1996)

Hagberg, G.; Burlina, A.; Mader, I.; Roser, W.; Radue, E.; Seelig, J.: In Vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification. Magnetic Resonance in Medicine 34 (2), S. 242 - 252 (1995)

Roser, W.; Hagberg, G.; Mader, I.; Brunnschweiler, H.; Radue, E.; Seelig, J.; Kappos, L.: Proton MRS of Gadolinium-enhancing MS Plaques and Metabolic Changes in Normal-Appearing White Matter. Magnetic Resonance in Medicine 33 (6), S. 811 - 817 (1995)

Garreffa, G.; Hagberg, G.; Indovina, L.: Physics of Hybrid Imaging. In: PET-CT and PET-MRI in Neurology, S. 3 - 12 (Hg. Ciarmiello , A.; Mansi, L.). Springer, Cham, Switzerland (2016)

Hagberg, G.; Tuzzi, E.: Phase Variations in fMRI Time Series Analysis: Friend or Foe? In: Advanced Brain Neuroimaging Topics in Health and Disease: Methods and Applications, S. 81 - 113 (Hg. Papageorgiou, T.; Christopoulos, G.; Smirnakis, S.). InTech, Rijeka, Croatia (2014)

Cherubini, A.; Luccichenti, G.; Fasano, F.; Hagberg, G.; Perán, P.; Di Salle, F.; Esposito, F.; Scarabino, T.; Sabatini, U.: Nerve Pathways with MR Tractography. In: High Field Brain MRI, S. 79 - 90 (Hg. Salvolini, U.; scarabino, T.). Springer, Berlin, Germany (2006)

Giugni, E.; Luccichenti, G.; Hagberg, G.; Cherubini, A.; Fasano, F.; Sabatini, U.: High-Field Neuroimaging in Traumatic Brain Injury. In: High Field Brain MRI, S. 169 - 176 (Hg. Salvolini, U.; Scarabino, T.). Springer, Berlin, Germany (2006)

Luccichenti, G.; Perán, P.; Cherubini, A.; Giugni, E.; Scarabino, T.; Hagberg, G.; sabatini, U.: High-Field 3 T Imaging of Alzheimer Disease. In: High Field Brain MRI, S. 201 - 207 (Hg. Salvolini, U.; Scarabino, T.). Springer, Berlin, Germany (2006)

Perán, P.; Luccichenti, G.; Cherubini, A.; Hagberg, G.; Sabatini, U.: High-Field Neuroimaging in Parkinson’s Disease. In: High Field Brain MRI, S. 194 - 200 (Hg. Salvolini, U.; Scarabino, T.). Springer, Berlin, Germany (2006)

Bianciardi, M.; Sirabella, P.; Hagberg, G.; Giuliani , A.; Zbilut, J.; Colosimo, A.: Analyzing Spatial Distributions of FMRI "Bold" Signals by RQA Variables. In: International Meeting Complexity in the Living: A Problem-Oriented Approach, S. 238 - 243 (Hg. Benigni, R.; Colosimo, A.; Giuliani, A.; Sirabella, P.; Zbilut, J.). International Meeting Complexity in the Living: A Problem-Oriented Approach, Roma, Italy, 28. September 2001 - 30. September 2001. Istituto Superiore di Sanità, Roma, Italy (2004)

Hagberg, G.; Thomas, S.; Hirt, B.; Scheffler, K.: Quantitative MRI of the human brain ex vivo and in vivo: the role of local magnetic field gradients. In Magnetic Resonance Materials in Physics, Biology and Medicine, 38 (Supplement 1), 082, S. S133 - S134. 41st Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB 2025), Marseille, France, 08. Oktober 2025 - 11. Oktober 2025. No longer published by Elsevier, Amsterdam (2025)

Osenberg, A.; Bause, J.; Martin, P.; Scheffler, K.; Hagberg, G.: Cortical thickness of the human brain with MP2RAGE at 9.4T: methodological challenges and histology. In Magnetic Resonance Materials in Physics, Biology and Medicine, 38 (Supplement 1), 422, S. S663 - S665. 41st Annual Scientific Meeting of the European Society for Magnetic Resonance in Medicine and Biology (ESMRMB 2025), Marseille, France, 08. Oktober 2025 - 11. Oktober 2025. No longer published by Elsevier, Amsterdam (2025)